Guosheng Capital

Guosheng Capital is a prominent Chinese investment management firm based in Shanghai, serving as a strategic investment platform for the state-owned Shanghai Guosheng Group. The firm is a central figure in the life sciences sector, primarily through its management of the Shanghai Biomedical Industry Equity Investment Fund, which has a target size of 50 billion RMB. Its investment strategy focuses on the entire healthcare value chain, including innovative drug discovery, high-end medical devices, and healthcare services. By bridging government resources with market-oriented operations, Guosheng Capital supports the industrialization of medical research and the growth of leading biotech enterprises in China. The firm plays a pivotal role in Shanghai's ambition to become a global hub for biopharmaceutical innovation.